Literature DB >> 21926857

Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.

Wei-dong Zhang1, Yu-bao Guan, Chuan-xing Li, Xiao-bo Huang, Fu-jun Zhang.   

Abstract

PURPOSE: The aim of the study was to present the computed tomography (CT) and fluorine 18 (F) fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT imaging findings of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma and evaluate their roles in the follow-up of this tumor.
METHODS: Computed tomography and FDG-PET/CT imaging findings of 18 cases of pathologically proven pulmonary MALT lymphoma were reviewed retrospectively.
RESULTS: Multiple and solitary lesions were detected in 15 and 3 patients, respectively. Of those patients with multiple pulmonary lesions, 12 were bilateral, and 3 were unilateral. A total of 51 pulmonary lesions were identified in 18 patients, which included lesions with consolidation (31/51), mass and nodule (12/51), and ground-glass attenuation (8/51). F fluorodeoxyglucose-PET/CT imaging (n = 8) revealed increased FDG uptake in all lesions in 8 cases. At follow-up, 3 patients experienced complete remission, 10 had partial remission, and 2 remained stable.
CONCLUSIONS: Computed tomography and FDG-PET/CT images of the pulmonary MALT lymphoma usually reveal multiple, bilateral consolidations, masses, or nodules with air bronchogram and increased FDG uptake. Computed tomography and FDG-PET/CT imaging play important roles in the diagnosis and follow-up of patients with pulmonary MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926857     DOI: 10.1097/RCT.0b013e318227a661

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

1.  Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET/CT and CT findings in 28 patients.

Authors:  Domenico Albano; Andrea Borghesi; Giovanni Bosio; Mattia Bertoli; Roberto Maroldi; Raffaele Giubbini; Francesco Bertagna
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

2.  Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.

Authors:  Shunan Qi; May Y Huang; Yong Yang; Heiko Schöder; Sewit Teckie; Ariela Noy; Karen Chau; Joachim Yahalom
Journal:  Blood Adv       Date:  2018-03-27

3.  An Unusual Presentation of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma as Diffuse Pulmonary Infiltrates with Spontaneous Regression.

Authors:  Hye Seon Kang; Hea Yon Lee; Seung Joon Kim; Seok Chan Kim; Young Kyoon Kim; Gyeong Sin Park; Kyo Young Lee; Jung Im Jung; Ji Young Kang
Journal:  Cancer Res Treat       Date:  2014-09-15       Impact factor: 4.679

4.  Hematologic neoplasms: interpreting lung findings in chest computed tomography.

Authors:  P Calvillo Batllés; J Carreres Polo; J Sanz Caballer; M Salavert Lletí; L Compte Torrero
Journal:  Radiologia       Date:  2015-08-24

Review 5.  Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Authors:  Francesca Sanguedolce; Magda Zanelli; Maurizio Zizzo; Alessandra Bisagni; Alessandra Soriano; Giorgia Cocco; Andrea Palicelli; Giacomo Santandrea; Cecilia Caprera; Matteo Corsi; Giulia Cerrone; Raffaele Sciaccotta; Giovanni Martino; Linda Ricci; Francesco Sollitto; Domenico Loizzi; Stefano Ascani
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

6.  Value of multidetector computed tomography in the diagnosis of mucosa-associated lymphoid tissue-lymphomas in the parotid gland: A case report and review of the literature.

Authors:  Yue Dong; Feng Wen; Aijun Shi; Hong Wei Guan; Ying Ge; Yuan Jiang
Journal:  Oncol Lett       Date:  2013-12-20       Impact factor: 2.967

7.  Comparison of radiologic characteristics and pathological presentations of primary pulmonary lymphoma in 22 patients.

Authors:  Yanchao Wang; Jun Han; Fantao Zhang; Zhaoyu Wang; Dahai Zhao; Xuan Wang; Ningxin Wu; Rongjian Lu; Chongchong Wu; Jie Gao; Lei Pan; Xinying Xue
Journal:  J Int Med Res       Date:  2019-12-27       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.